相关期刊:《Chinese Medical Journal》《Signal Transduction and Targeted Therapy》《Medical Bulletin of Shanghai Jiaotong University》《World Journal of Meta-Analysis》更多>>
supported by the National Natural Science Foundation of China(82472802 and 82073258);Natural Science Foundation of Shanghai(23ZR1448600).
Acute myeloid leukemia(AML)is a devastating disease with a median age of diagnosis of over 60 years.Thus,most AML patients are not eligible for intensive chemotherapy.Relapse remains common in patientswith AML despite...
BACKGROUND Haploidentical hematopoietic stem cell transplantation(Haplo-HSCT)is often performed in children with hematologic malignancies.Faced with the gap in the literature regarding the approach to experiences rela...
Introduction: Hematological malignancies (HM) are relatively frequent nosological entities within the structure of morbidity by malignant tumors, exhibiting a severe evolution, restrained prognosis and negative socio-...
The paper presents the key milestones and outcomes of 65-year studies of the carcinogenic consequences of accidental radiation exposure of the population of the Ural region.The radioactive contamination of the Techa R...
This work was supported by a grant from the National Institutes of Health,CA076167。
Myeloid and lymphoid neoplasms with eosinophilia and FGFR1 rearrangements(MLN-eo FGFR1)disease is derived from a pluripotent hematopoietic stem cell and has a complex presentation with a myeloproliferative disorder wi...
supported in part by the National Natural Science Foundation of China(Grant 81102248);Science and Technology Plan Projects of Guangdong(Grant 2014A020212695);Natural Science Foundation of Guangdong Province,Major Special Project of Guangzhou Science and Technology and Information Bureau(Grant 122400037)。
The ability to identify a specific type of leukemia using minimally invasive biopsies holds great promise to improve the diagnosis,treatment selection,and prognosis prediction of patients.Using genome-wide methylation...
The project described was supported by the DHHS grant R43CA177067(Uckun FM)from the National Cancer Institute.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.Uckun FM was also supported in part by DHHS grants P30CA014089,U01-CA-151837,R01CA-154471 and R21-CA-164098(Uckun FM)from the National Cancer Institute;by the V-Foundation,Nautica Triathlon as well as the Ronald McDonald House Charities of Southern California.
Aim:CD22ΔE12 as an oncogenic driver lesion in aggressive and drug-resistant B-precursor acute lymphoblastic leukemia(BPL)cells.The purpose of the present study was to identify the CD22ΔE12-specific signature transcr...
We apologize to the scientists who made contributions to the field, but have not been cited due to the space limitations. This work was sup- ported in part by the National Natural Science Foundation of China (Grant Nos. 81270601, 81328016, and 81470306) and Leukemia Research Innovative Team of Zhejiang Province (2011 R50015).
Chronic myeloid leukemia (CML) is a clonal myeloprolif- erative disorder characterized by a chromosome translocation that generates the Bcr-Abl oncogene en- coding a constitutive kinase activity. Despite remarkable ...
This study was supported by the National Basic Research Program of China (973 Program, No. 2013CB911000) and the National Nature Science Foundation of China (No. 30971602, 81272929).Acknowledgements: We thank Dr. Chi Zhenfen for help with cell culture.
Background Both in vitro and in vivo data have demonstrated the TGFBI gene functions as a putative tumor suppressor and is frequently downregulated in human tumors of different histological types.The hypermethylation ...